Rectal neuroendocrine tumors: Current advances in management, treatment, and surveillance

Camilla Gallo, Roberta Elisa Rossi, Federica Cavalcoli, Federico Barbaro, Ivo Boskoski, Pietro Invernizzi, Sara Massironi

Risultato della ricerca: Contributo in rivistaArticolo in rivista


Rectal neuroendocrine neoplasms (r-NENs) are considered among the most frequent digestive NENs, together with small bowel NENs. Their incidence has increased over the past few years, and this is probably due to the widespread use of endoscopic screening for colorectal cancer and the advanced endoscopic procedures available nowadays. According to the current European Neuroendocrine Tumor Society (ENETS) guidelines, well-differentiated r-NENs smaller than 10 mm should be endoscopically removed in view of their low risk of local and distant invasion. R-NENs larger than 20 mm are candidates for surgical resection because of their high risk of distant spreading and the involvement of the muscularis propria. There is an area of uncertainty regarding tumors between 10 and 20 mm, in which the metastatic risk is intermediate and the endoscopic treatment can be challenging. Once removed, the indications for surveillance are scarce and poorly codified by international guidelines, therefore in this paper, a possible algorithm is proposed.
Lingua originaleEnglish
pagine (da-a)1123-1138
Numero di pagine16
RivistaWorld Journal of Gastroenterology
Stato di pubblicazionePubblicato - 2022


  • Endoscopic submucosal dissection
  • Endoscopy
  • Rectal neuroendocrine tumors
  • Resectable advanced disease
  • Systemic therapy


Entra nei temi di ricerca di 'Rectal neuroendocrine tumors: Current advances in management, treatment, and surveillance'. Insieme formano una fingerprint unica.

Cita questo